Biotech

3 Strategies for Shorting the Bursting Biotech Bubble

3 Strategies for Shorting the Bursting Biotech Bubble

Follow any of these three easy to understand, step-by-step strategies that detail exactly how any investor can profit from the collapse in biotech.  The biotech sector is a bursting bubble. Unfortunately, making money from a bursting bubble requires investors to go short on a stock. Shorting a stock exposes an investor to a theoretically infinite […]

3 Small Cap Biotechs Ripe for a Takeover

3 Small Cap Biotechs Ripe for a Takeover

Big biotech is about to go on a shopping spree to replenish their pipelines as many small cap biotechs are selling for lows not seen since 2011. Here are three likely candidates that might get snatched up soon for big premiums. Few sectors of the stock market have been hit harder in 2016 than the […]

3 Imminent Small Cap M&A Targets

3 Imminent Small Cap M&A Targets

M&A activity is about to really heat up in the small cap sector and these three picks look like imminent targets. Large multi-national companies are starved for growth and, with their war-chests of cash, will spend heavily on fast-growth small cap stocks. M&A activity is about to really heat up in the small cap sector […]

Top 3 Small Caps to Own for 2016

Top 3 Small Caps to Own for 2016

With screaming fast earnings growth and very favorable valuations, these three stocks have great chances of handsomely rewarding their shareholders in the New Year. After a difficult 2015, investors should look forward to strong stock performance in 2016. For example, 2016 is a Presidential Election year and since 1979, the S&P 500 Index has risen […]

Big Pharma’s Big Strategy to Avoid Slowing Growth

Big Pharma’s Big Strategy to Avoid Slowing Growth

It’s no secret that many analysts believe big pharma and biotech stocks are in a bubble. However, some companies are using this high-risk strategy to generate new growth opportunities while staving off a slowdown. Parts of the pharma space has been a real head-scratcher of late. Teva Pharmaceuticals (NYSE: TEVA) pursuit of Mylan (NYSE: MYL) […]

The End of Google Is Here, Part II

The End of Google Is Here, Part II

There’s no denying Google’s dominance since its 2004 IPO, but the end of this juggernaut’s growth story is here. Investors looking for life-changing returns must look elsewhere, and the best place for growth is in biotech. New technologies are allowing for more drugs to be synthesized and approved faster than ever, and with a large […]

The End of Google’s Reign is Near

The End of Google’s Reign is Near

The end of Google’s reign as the king of search is near. Competitors are eating away market share and growth is sputtering. Trying to cherry-pick the next winner in search, however, is akin to rolling dice at a casino. All luck. Where investors are going to make their millions is in this red hot sector […]

Is a Tech Bubble Worse than 2000 Ready to Burst?

Is a Tech Bubble Worse than 2000 Ready to Burst?

Mark Cuban, the billionaire technology entrepreneur, thinks the current bubble in tech will be worse than 2000. With the Nasdaq flirting with record highs and certain tech stocks trading at sky-high valuations, investors should be wary. In this article, we explain everything you need to know about what’s going on in the technology sector and […]